cbdMD, Inc. $YCBD

What the company doesAI summary of filing

cbdMD, Inc. is a revenue-generating consumer wellness company that develops, manufactures, markets, and sells dietary supplement products, the majority anchored by hemp-derived cannabinoids including CBD and Delta-9 THC formulations, along with functional products addressing wellness needs such as sleep, recovery, and stress management. The company operates a multi-brand portfolio including cbdMD (flagship oils, gummies, capsules, and topicals), Paw CBD (pet wellness products), ATRX (functional mushroom ingredients), and Herbal Oasis (THC-infused beverages), distributed through direct-to-consumer e-commerce, online marketplaces, and wholesale channels to national and regional retailers. The company generated revenue of approximately 77% from e-commerce and 23% from wholesale in fiscal 2025, with a net operating loss of $2.1 million in fiscal 2025 compared to $3.3 million in fiscal 2024. [10-K 2025-12-19]

Segments: cbdMD (flagship CBD and Delta-9 THC products), Paw CBD (pet wellness), ATRX (functional mushroom ingredients), Herbal Oasis (THC-infused beverages)